Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Q32 Bio (QTTB) Other Non-Current Assets (2017 - 2025)

Historic Other Non-Current Assets for Q32 Bio (QTTB) over the last 9 years, with Q3 2025 value amounting to $647000.0.

  • Q32 Bio's Other Non-Current Assets changed 0.0% to $647000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $647000.0, marking a year-over-year change of 0.0%. This contributed to the annual value of $647000.0 for FY2024, which is 8854.26% down from last year.
  • Q32 Bio's Other Non-Current Assets amounted to $647000.0 in Q3 2025, which was down 0.0% from $647000.0 recorded in Q2 2025.
  • Q32 Bio's 5-year Other Non-Current Assets high stood at $5.6 million for Q1 2023, and its period low was $276000.0 during Q1 2022.
  • Moreover, its 5-year median value for Other Non-Current Assets was $1.2 million (2021), whereas its average is $2.1 million.
  • Its Other Non-Current Assets has fluctuated over the past 5 years, first surged by 194601.45% in 2023, then crashed by 8854.26% in 2024.
  • Over the past 5 years, Q32 Bio's Other Non-Current Assets (Quarter) stood at $2.0 million in 2021, then crashed by 85.87% to $276000.0 in 2022, then soared by 1946.01% to $5.6 million in 2023, then plummeted by 88.54% to $647000.0 in 2024, then changed by 0.0% to $647000.0 in 2025.
  • Its Other Non-Current Assets stands at $647000.0 for Q3 2025, versus $647000.0 for Q2 2025 and $647000.0 for Q1 2025.